loader
Please Wait
Applying Filters...

Seqens Seqens

X

List of All Manufacturers & Suppliers for 2371057 Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 AMLODIPINE (AMLODIPINE BESYLATE) (1)

02 TELMISARTAN (1)

filter

01 BOEHRINGER INGELHEIM (CANADA) LTD LTEE (2)

filter

01 TABLET (2)

filter

01 10MG (1)

02 80MG (1)

filter

01 Canada (2)

URL Supplier Web Content
TABLET
80MG
TWYNSTA
Canada
2371057
14/28
Prescription
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET
10MG
TWYNSTA
Canada
2371057
14/28
Prescription
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for CTD TGA MCC DOSSIER APPLICATION 2371057

Looking for CTD TGA MCC DOSSIER APPLICATION 2371057 2

19

Boehringer Ingelheim GmbH, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is TELMISARTAN, with a corresponding application number 2371057 and regulatory information .

proudly manufactured in the

Boehringer Ingelheim GmbH's TWYNSTA TABLET, medication with 80MG of TELMISARTAN.

18

Boehringer Ingelheim GmbH, based in Germany, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.

One of their notable products is AMLODIPINE (AMLODIPINE BESYLATE), with a corresponding application number 2371057 and regulatory information .

proudly manufactured in the

Boehringer Ingelheim GmbH's TWYNSTA TABLET, medication with 10MG of AMLODIPINE (AMLODIPINE BESYLATE).

Post Enquiry
POST ENQUIRY